IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
468.20
-2.54 (-0.54%)
At close: Jul 19, 2024, 4:00 PM
461.10
-7.10 (-1.52%)
Pre-market: Jul 22, 2024, 4:21 AM EDT
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $3.72B in the twelve months ending March 31, 2024, with 8.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $964.10M with 7.10% year-over-year growth. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.
Revenue (ttm)
$3.72B
Revenue Growth
+8.57%
P/S Ratio
10.38
Revenue / Employee
$338,623
Employees
11,000
Market Cap
38.67B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
Dec 31, 2005 | 638.10M | 88.91M | 16.19% |
Dec 31, 2004 | 549.18M | 73.19M | 15.38% |
Dec 31, 2003 | 475.99M | 63.32M | 15.34% |
Dec 31, 2002 | 412.67M | 26.59M | 6.89% |
Dec 31, 2001 | 386.08M | 18.65M | 5.08% |
Dec 31, 2000 | 367.43M | 9.06M | 2.53% |
Dec 31, 1999 | 358.37M | 36.66M | 11.39% |
Dec 31, 1998 | 321.71M | 58.74M | 22.34% |
Dec 31, 1997 | 262.97M | -4.71M | -1.76% |
Dec 31, 1996 | 267.68M | 79.08M | 41.93% |
Dec 31, 1995 | 188.60M | 62.24M | 49.25% |
Dec 31, 1994 | 126.36M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Centene | 155.52B |
Takeda Pharmaceutical | 28.16B |
GE HealthCare Technologies | 19.50B |
IQVIA Holdings | 15.07B |
Haleon | 14.31B |
Biogen | 9.66B |
Alcon | 9.56B |
Agilent Technologies | 6.59B |
IDXX News
- 27 days ago - IDEXX Laboratories to Release 2024 Second Quarter Financial Results - Business Wire
- 6 weeks ago - IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis - PRNewsWire
- 2 months ago - IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day - Business Wire
- 2 months ago - IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar - Reuters
- 2 months ago - IDEXX Laboratories Announces First Quarter Results - Business Wire
- 3 months ago - IDEXX Laboratories to Release 2024 First Quarter Financial Results - Business Wire
- 5 months ago - IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
- 5 months ago - IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect - PRNewsWire